Treatment of Bacterial Vaginosis With Oral Tinidazole

Mission Pharmacal

Status and phase: Completed; Phase 3

Conditions: Bacterial Vaginosis

Treatments: Drug: Tinidazole

Study type: Interventional

Funder types: Industry

Identifiers

NCT00229216

T-500

Details and patient eligibility

About

The purpose of this study is to confirm the safety and efficacy of oral tinidazole for the treatment of bacterial vaginosis.

Full description

Tinidazole is a second-generation nitroimidazole i.e. an updated form of the standard drug used to treat bacterial vaginosis (metronidazole). Two dosing regimens are being compared to placebo to treat bacterial vaginosis, one of the most common vaginal infections.

Enrollment: 200 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Clinical and microbiological diagnosis of bacterial vaginosis -

Exclusion criteria

Other sexually transmitted disease

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind